Fingerprint
Dive into the research topics of 'Pharmacological and structural characterizations of naquotinib, a novel third-generation EGFR tyrosine kinase inhibitor, in EGFR-mutated non–small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically